| Date | Title | Description |
| 17.09.2026 | Hologic Leads U.S. Adoption as Breast Cancer Diagnostics Market Rises from USD 5,878.0 million in 2025 to USD 12,451.97 million by 2036 at 6.9% CAGR | ROCKVILLE, MD /Sept 17, 2026 – According to Fact.MR estimates, the breast cancer diagnostics market stood at USD 5,878.0 million in 2025. The market is projected to reach USD 6,389.41 million in 2026 and climb to USD 12,451.97 million by 20... |
| 28.08.2026 | Breast Cancer Liquid Biopsy Market Trends: Precision Oncology and Minimally Invasive Diagnostics Driving Growth | The breast cancer liquid biopsy market is emerging as a promising segment of precision oncology as healthcare providers increasingly seek minimally invasive approaches for cancer detection, monitoring, and treatment planning. Liquid biopsy ... |
| 10.06.2026 | SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting | Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board
BOSTON and ROLLE, Switzerland, June 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (Nas... |
| 27.04.2026 | AI Drives Europe's Tech Boom: Billions Flow to Security, Cloud, and Next-Gen Innovation | European tech funding surged past €632 million. AI innovation drives significant investment. Cloudsmith secured $72M for AI software supply chain security. Verda raised $117M for AI cloud infrastructure. Acquisitions are robust, including A... |
| 24.04.2026 | Verda raises $117M, Aleph Alpha to be acquired, and solving the quantum bottleneck | This week, we tracked more than 65 tech funding deals worth over €632 million and over 5 exits, M&A transactions, rumours, and related news stories across Europe.
If email is more your thing, you can always subscribe to our newsletter a... |
| 15.01.2026 | Oncology’s Largest Dataset: ConcertAI and Foundation Medicine Unveil Half-Million Patient Clinico-Genomic Powerhouse | What You Should Know
– ConcertAI and Foundation Medicine have announced a major strategic collaboration to integrate their massive data assets, creating a dataset of nearly half a million patients.
– By pairing Foundation Medicine’s de-iden... |
| 25.12.2025 | Manifold Fuels Life Sciences AI with $18 Million Series B | Manifold raised $18 million in Series B funding, bringing its total to $40 million, to bolster its vertical AI platform for life sciences. Reach Capital led the round, backing Manifold's specialized "Agent OS" and secure, collabor... |
| 24.12.2025 | Manifold: $18 Million Series B Raised To Expand Vertical AI Platform For Life Sciences | Manifold, an AI platform focused on life sciences workflows from discovery through clinical and precision care, has raised $18 million in a Series B financing led by Reach Capital, with participation from SilverArc Capital, Industry Venture... |
| 12.11.2025 | Laboratory Economics Issues Research Report on U.S. Anatomic Pathology Market | Laboratory Economics has just published the most comprehensive and detailed market research report available on the U.S. Anatomic Pathology Market. This is an ideal resource for preparing business plans and market strategies.
POUGHKEEPSIE, ... |
| 14.04.2025 | Swiss HealthTech startup CGC Genomics raises €1.7 million for regulated GenAI platform | Basel-based CGC Genomics has raised €1.7 million in pre-Seed funding to innovate the interpretation of cancer genome data with its GenAI platform Qnomx, bringing to market their regulatory-grade generative AI solution for clinical decision ... |
| 03.12.2024 | Paris-based Orakl Oncology raises €11 million to launch AI-powered drug development tools | Orakl Oncology, a French oncology startup focused on cancer drug development, has secured €11 million in seed funding.
The round was led by Singular with participation from Bpifrance, including the Grand Prix i Lab, and existing investors. ... |
| 09.11.2024 | The Rising Tide of Biotech: Boston's Role in Global Health Transformation | Boston's biotech industry is a lighthouse in the stormy seas of global health challenges. It shines brightly, guiding innovation and collaboration. This city, with its prestigious universities and a vibrant network of biotech firms, has bec... |
| 04.11.2024 | The Impact of Boston’s Biotech Industry on Global Health | Share
Tweet
Share
Share
Email
The biotech industry in Boston is more than just a source of jobs or a pillar of the local economy; it is a powerful force in the global fight for better health. Known for its prestigious universities, research... |
| 07.08.2024 | Pangea Biomed Partners with Hadassah to Develop Cancer Treatment | What You Should Know:
– Pangea Biomed, the startup behind the world’s most advanced cancer response predictor, ENLIGHT, is announcing a strategic collaboration with the Sharett Institute of Oncology and Hadassah Cancer Research Institute (H... |
| 17.06.2024 | Companion Diagnostics Market Size to Reach $13.74 Billion by 2030: Latest Report by Vantage Market Research | According to a market research study published by Vantage Market Research, the demand analysis of Global Companion Diagnostics Market size revenue was valued at approximately $5.59 Bn in 2022 and is expected to reach around $13.74 Bn by 203... |
| 09.02.2023 | UnitedHealthcare Provides Commercial Coverage for FoundationOne CDx and FoundationOne Liquid CDx in Multiple Companion Diagnostic Indications | Foundation Medicine, a pioneer in molecular profiling for cancer, announced that UnitedHealthcare commercial plans will cover FoundationOneCDx as a companion diagnostic in all solid tumors for patients with unresectable or metastatic cancer... |
| 14.11.2022 | Foundation Medicine Launches FoundationReport+, a New Digital Reporting Experience to Streamline Precision Cancer Care | Innovative and interactive reporting functionality offers healthcare providers additional tools to complement integrated electronic health records and make it easier to review and act on results
Foundation Medicine, a pioneer in molecular p... |
| 10.05.2022 | The Exceptional Women Awardees Foundation (EWA) announces selection of Dymeka Harrison, Chief Commercial Officer, Foundation Medicine, as a Winter 2022 Awardee | Dymeka Harrison, Chief Commercial Officer, Foundation Medicine “We are delighted to have Dymeka join our network! Not only does she have an extensive marketing background, but an exceptional ability to bolster a team’s strengths and weaknes... |
| 29.11.2021 | NanoTemper Technologies again "Innovator of the Year" | NanoTemper Technologies GmbH from Munich has taken first place in the TOP 100 innovation competition in size category B (51 to 200 employees). The company, which offers biophysical laboratory measuring instruments for basic research and dru... |
| 26.08.2021 | Foundation Medicine, Epic partner to integrate genomic insights into EHR | Foundation Medicine and Epic are partnering to enable clinicians to access genomic profiling and other testing services directly through their EHR system.
Announced Thursday, the partnership aims to improve clinical workflow efficiency and ... |
| 02.08.2021 | Chugai Pharmaceutical : Launches FoundationOne Liquid CDx Cancer Genomic Profile as the First Blood-based Comprehensive Genomic Profiling Test for Solid Tumors in Japan | Chugai Launches FoundationOne Liquid CDx Cancer Genomic Profile as the First Blood-based Comprehensive Genomic Profiling Test for Solid Tumors in Japan
FoundationOne Liquid CDx Cancer Genomic Profile is now available for use as a comprehens... |
| 09.03.2021 | Foundation Medicine and InformedDNA® Collaborate to Improve Access to Genetic Counseling for Advanced Cancer Patients | CAMBRIDGE, Mass. & ST. PETERSBURG, Fla.--(BUSINESS WIRE)--Mar 9, 2021--
Foundation Medicine, Inc. and InformedDNA, the nation’s largest independent provider of genetics services, today announced a collaboration that will enable physicia... |
| 03.12.2020 | Facing Prostate Cancer with the Help of Precision Medicine | (BPT) - Joel H., 62, was once more active than most people his age – walking from the fuel truck to the plane and back, multiple times a day at a South Carolina airport.
“It used to be nothing to put 10 miles on my feet every single day,” J... |
| 03.12.2020 | Facing Prostate Cancer with the Help of Precision Medicine | (BPT) - Joel H., 62, was once more active than most people his age – walking from the fuel truck to the plane and back, multiple times a day at a South Carolina airport.
“It used to be nothing to put 10 miles on my feet every single day,” J... |
| 28.08.2020 | Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval | Where traditional tissue biopsy is a painful and cumbersome process that consists of taking tissue samples directly from a tumor so that they can be tested for genetic biomarkers that may enable the use of targeted therapy, liquid biopsy en... |
| 02.07.2020 | M&A Roundup: Microsoft buys CyberX, Mass. eHealth Collaborative winds down | Boston startups signed and sealed many deals in June.
Notable deals included Microsoft's purchase of network security provider CyberX and Bay Area startup Grove Collaborative's acquisition of the Cambridge-based ingestible skincare startup ... |
| 05.08.2019 | AI in healthcare: From data gaps to data democratization | Note: This article is the second of a two-part series. The quotes in this article have been edited and condensed for clarity.
In the panel, “The Data Problem in Scaling Artificial Intelligence” in Healthcare at the recent MedCity CONVERGE c... |
| 29.07.2019 | What are the opportunities for AI in healthcare and what Big Data challenges lie ahead? | Note: This article is the first of a two-part series. The quotes in this article have been edited and condensed for clarity.
Although artificial intelligence in healthcare is an area of intense interest, exploring the topic is akin to peeli... |
| 03.06.2019 | What’s health tech’s evolving role in cancer treatment? Learn more at the CONVERGE conference in Philadelphia! | Through a mix of provocative conversations, interactive networking, and a showcase of the hottest startups, you’ll get actionable insight into how AI, big data, precision medicine and more are transforming cancer treatment.
Among the highli... |
| 09.05.2019 | Don’t miss this innovation in cancer treatment conference in Philadelphia | A panel discussion will explore how precision medicine can be the key to population health. Experts from Cancer Treatment Centers of America, Color and other organizations will talk about the synergies between precision medicine and populat... |
| 01.11.2018 | Pricey precision medicine often financially toxic for cancer patients | When Kristen Kilmer was diagnosed with incurable breast cancer at age 38, her first thought was of her 8-year-old daughter. Kilmer lost her own mother as a teenager and was determined to get more time with her only child.
Kilmer searched fo... |
| 19.06.2018 | Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy | “This is important to our personalized healthcare strategy as we believe molecular insights and the broad availability of high quality comprehensive genomic profiling are key enablers for the development of, and access to, new cancer treatm... |
| 21.11.2017 | FDA treads carefully on molecular diagnostics | No one was really surprised by these decisions — the FDA telegraphed some of them in its January 2017 discussion paper. The context goes back to the agency’s 2014 draft guidance, in which it proposed more aggressive regulation for laborator... |
| 15.06.2017 | Pop-up trial sites and the future of personalized oncology care | As everyone knows, these technologies don’t exist in a vacuum. The realities of healthcare too often get in the way and limit medical advances to patients at major academic institutions.
Thankfully, there’s a technology solution for expandi... |
| 03.11.2016 | Foundation and Flatiron launch expansive clinico-genomic cancer database | Foundation Medicine and Flatiron Health today announced a new initiative to assemble and curate one of the largest-ever clinico-genomic databases, built around the electronic health records of 20,000 cancer patients.
It’s not the first time... |
| 31.10.2016 | Third Rock Ventures closes $616 million healthcare fund | Fund IV has not yet begun investing, according to a company representative, but the firm has established a strong track record with its first three funds. In less than 10 years, Third Rock has invested in 40 companies, advancing 40 clinical... |
| 15.09.2015 | The Best Things Come In Threes | Brian Wilcove Contributor
Brian Wilcove is a partner with Artiman Ventures.
More posts by this contributor
The Best Things Come In Threes
The ’80s were fun, fabulous and economically stimulating. What brought us Michael Jackson, the Sony Wa... |
| 20.08.2015 | 6 Precision Medicine partnerships reflective of the new Intel Collaborative Cancer Cloud | Intel just announced it has created a “Collaborative Cancer Cloud,” a precision medicine analytics platform built in partnership with several academic centers. It’s meant to allow researchers from various institutions share the deidentified... |
| 29.04.2015 | Rebranded healthcare VC changes investment priorities with $200M fund targeting health IT | Investors in the new fund include healthcare systems, payers, and large labs as well as traditional LPs and offshore investors.
In an indication of how lines between segments of the healthcare industry are blurring, Greeley remarked that me... |
| 03.04.2015 | Bill Maris To Talk Longevity At Disrupt NY | At just 40 years old, Bill Maris is on a mission to save the world — with his investments. Bloomberg recently highlighted Maris’s quest to improve the quality and longevity of human life. This quest is evident in Google Ventures’ growing bi... |
| 02.12.2014 | Big data meets genomic profiling to improve clinical trials for cancer drugs | OncologyCloud helps cancer centers and physicians aggregate clinical, practice management and billing data. Its application for providers is a Web-based program designed to integrate a cancer center’s disparate data systems and give real-ti... |
| 13.03.2014 | Venture capitalists face a more competitive, global market | 2013 was a turning point for venture capital.
According to financial services firm Ernst&Young, global venture capital investment in 2013 increased 2 percent compared to 2012, to $48.5 billion. Meanwhile, economic conditions improved in... |
| 13.03.2014 | Venture capitalists face a more competitive, global market | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
2013 was a turning point for venture capital.
Acc... |
| 25.09.2013 | Foundation Medicine shares pop 89 percent after $106M IPO | The Byers family must be ready to pop a bottle of champagne. Father Brook and son Blake, both Silicon Valley venture capitalists, made early bets in Foundation Medicine, a diagnostics company that hit the public markets this week.
Above: Kl... |
| 30.07.2013 | UPDATED: Foundation Medicine seeks $86.3M IPO amid chase for reimbursement | Foundation Medicine has bought a ticket to ride the IPO train. The Cambridge, MA-based company, which provides genomic tests for cancer patients and drug researchers, has proposed an $86.3 million initial public offering. There have been ne... |
| 29.07.2013 | Foundation Medicine Lays Groundwork For $86M IPO | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The appetite for biotech IPOs is as rabid as it has been in a decade. Will that good fortune seep into diagnostics? Now that Foundation Medicine has become the latest to step ... |
| 26.04.2013 | Google Ventures is betting its money on these 8 healthcare and life sci companies | DNAnexus The bioinformatics company that provides DNA data management and analysis for sequencing centers and researchers was founded and is led by Andreas Sundquist. The Mountainview, California-based company provides data management suppo... |
| 22.01.2013 | Omics data company Syapse Inc. closes $3M series A led by ex-Facebook VP’s venture fund | The latest victory for the Palo Alto, California-based startup is closing a $3 million series A round led by The Social+Capital Partnership, a venture fund launched by former Facebook Vice President Chamath Palihapitiya. In its two years of... |
| 08.01.2013 | Funding Daily: If you haven’t got your health… | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Health dominated the deals channel today. Venture... |
| 08.01.2013 | Funding Daily: If you haven’t got your health… | Health dominated the deals channel today. Venture capital reports, funding rounds, and acquisitions kept the blood flowing though the industry’s veins and all signs point to 2013 being a huge year for health tech. Consumers, it seems, are t... |
| 08.01.2013 | Foundation Medicine Adds $13.5M to Series B |
CAMBRIDGE, MA, Foundation Medicine, Inc. today announced an expansion of its Series B financing, raising an additional $13.5 million and bringing the total raised in the round to $56 million.
>> Click here for more funding data on ... |
| 20.09.2012 | Foundation Medicine uses DNA, $42.5M to treat cancer | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Cigarettes, chemicals, and sunlight are well-know... |
| 20.09.2012 | Funding Daily: This one is for you, Cody Woo | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
My family dog growing up was named Cody, but for ... |
| 20.09.2012 | Foundation Medicine uses DNA, $42.5M to treat cancer | Cigarettes, chemicals, and sunlight are well-known causes of cancer, and people can respond accordingly to these risk factors by abstaining from smoking, buying organic, and slathering on the sunscreen. But what about the causes that can’t ... |
| 20.09.2012 | Foundation Medicine Closes $42.5M Series B Funding | Foundation Medicine, a Cambridge MA-based molecular technology company focused on cancer treatment, has closed a $42.5m Series B funding.
Backers include new investors Deerfield Management Company, Casdin Capital, Redmile Group, Roche Ventu... |
| 20.09.2012 | Foundation Medicine Bags $42.5M Series B |
CAMBRIDGE, MA, Molecular information company announced the completion of a $42.5 million Series B financing.
>> Click here for more funding data on Foundation Medicine
>> To export Foundation Medicine funding data to PDF and... |
| 05.06.2012 | Genomic analysis company gets $250K JumpStart investment | GenomOncology labels itself as a “genomics-as-a-service” business. The company predicts that the key to its success lay in its ability to quickly and accurately analyze data and report it to customers in an easily understood format.
Knowing... |
| 25.05.2012 | Software fast enough for custom-made cancer treatments? | GenomOncology is on the cusp of launching. It’s started raising money for salaries, software costs and tumor sequencing. It wants to work with biopharmaceutical companies, cancer research groups and academic centers. For biopharmas, the ide... |
| 29.03.2012 | The Cloud Will Cure Cancer | Editor’s note: Mark Kaganovich is founder of SolveBio and a doctoral candidate in genetics at Stanford University. Follow him on Twitter @markkaganovich.
Much ink has been spilled on the huge leaps in communications, social networking, and ... |
| 18.10.2011 | Foundation Medicine Closes $33.5M Expanded Series A Financing | Foundation Medicine, Inc., a Cambridge, MA-based cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine care, has closed an expanded Series A financing, bringing the total amount raised in the round to... |
| 23.08.2011 | Foundation Medicine Scores $10M |
Third Rock Ventures has previously invested in the company.
>> Click here for more funding data on Foundation Medicine
>> To export Foundation Medicine funding data to PDF and Excel, click here
CAMBRIDGE, MA, Foundation M... |
| 15.11.2010 | Personnel moves: Covidien pharma president Wright bows out | Covidien pharma president Wright bows out
Timothy Wright resigned as Covidien plc’s (NYSE:COV) senior vice president and president of its pharmaceuticals segment, effective Dec. 2, according to a Securities & Exchange Commission filing.... |
| 17.04.2010 | Foundation Medicine Completes $25M Series A Financing | Foundation Medicine, Inc., a Boston, MA-based personalized cancer medicine company that aims to bring comprehensive cancer genome analysis into routine clinical care, has completed a $25m Series A financing.
The round was led by Third Rock ... |
| - | Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval | A company whose acquisition by Roche was completed two years ago has become the second to win a Food and Drug Administration approval for a companion diagnostic test using liquid biopsy.
Cambridge, Massachusetts-based Foundation Medicine sa... |
| - | Next-generation liquid biopsy provides more options for advanced cancer patients | With a single tissue biopsy and comprehensive genomic profiling (CGP), people diagnosed with cancer have access to more information about their disease than ever before. These insights are rapidly advancing precision medicine and giving pat... |
| - | Omics data company Syapse Inc. closes $3M series A led by ex-Facebook VP’s venture fund | Sequencing the genome is one thing. Making sense of the data that generates is another.
That’s what Syapse Inc., self-proclaimed as “one of the largest repositories of human molecular profiles,” is helping laboratories and sequencing compan... |
| - | 11 health companies make the World Economic Group tech pioneer list | Nearly one-third of the 36 emerging technology pioneers chosen by the World Economic Forum this year have implications for the life sciences and health IT space. They represent robotics, noninvasive prenatal testing, using edible identifier... |
| - | AI in healthcare: From data gaps to data democratization | Note: This article is the second of a two-part series. The quotes in this article have been edited and condensed for clarity.
In the panel, “The Data Problem in Scaling Artificial Intelligence” in Healthcare at the recent MedCity CONVERGE c... |
| - | Foundation Medicine, Epic partner to integrate genomic insights into EHR | Foundation Medicine and Epic are partnering to enable clinicians to access genomic profiling and other testing services directly through their EHR system.
Announced Thursday, the partnership aims to improve clinical workflow efficiency and ... |
| - | Google Ventures is betting its money on these 8 healthcare and life sci companies | Google Ventures has been backing startups through its venture capital fund since 2009 and offers a pretty diverse range of services to entrepreneurs. Here’s a look at the eight healthcare and life science businesses among its portfolio comp... |
| - | Genomic analysis company gets $250K JumpStart investment | A bioinformatics company that’s developed software to analyze sequenced genomic data from cancer patients and their tumors has received a $250,000 investment from nonprofit business development group JumpStart.
Cleveland-area GenomOncology ... |
| - | Don’t miss this innovation in cancer treatment conference in Philadelphia | It feels like we’re on the cusp of great things in the development of cancer treatments. A wave of immunotherapy and gene therapy approvals could point the way forward in treating and curing certain forms of cancer. Pharma and technology co... |
| - | Rebranded healthcare VC changes investment priorities with $200M fund targeting health IT | Call it serendipity. When the management team behind Foundation Medical Partners decided to shift their investment strategy away from medical devices and therapeutics in favor of health IT, the name change to Flare Capital Partners coincide... |
| - | Measuring tumor mutational burden (TMB) can help inform immunotherapy decisions for cancer patients | Recent clinical data demonstrate the enormous impact that quantitative genomic biomarkers like tumor mutational burden (TMB) have made on the treatment landscape, especially in immunotherapy. TMB was a major topic at this year’s American As... |
| - | What’s health tech’s evolving role in cancer treatment? Learn more at the CONVERGE conference in Philadelphia! | Encouraging results from novel cancer treatments, as presented at ASCO, are offering new hope for cancer patients and deepening the potential of precision medicine. MedCity’s CONVERGE conference in Philadelphia June 19 will highlight how in... |
| - | What are the opportunities for AI in healthcare and what Big Data challenges lie ahead? | Note: This article is the first of a two-part series. The quotes in this article have been edited and condensed for clarity.
Although artificial intelligence in healthcare is an area of intense interest, exploring the topic is akin to peeli... |
| - | Third Rock Ventures closes $616 million healthcare fund | Third Rock Ventures announced Monday that it had closed its fourth fund — it’s largest, Third Rock Ventures IV — for an oversubscribed $616 million.
The Boston, Massachusetts-based firm now has a total of $1.9 billion in assets under manage... |
| - | FDA treads carefully on molecular diagnostics | Last week, the FDA tried to better define its role in molecular testing. The agency approved Memorial Sloan Kettering’s MSK-IMPACT, which profiles 468 genes to assess solid tumors, as an in vitro diagnostic (IVD). In addition, it elevated t... |
| - | Foundation and Flatiron launch expansive clinico-genomic cancer database | Foundation Medicine and Flatiron Health today announced a new initiative to assemble and curate one of the largest-ever clinico-genomic databases, built around the electronic health records of 20,000 cancer patients.
It’s not the first time... |
| - | Big data meets genomic profiling to improve clinical trials for cancer drugs | Google-backed health IT company Flatiron Health has inked an agreement with Foundation Medicine to bring together their different approaches to support cancer treatment, particularly for clinical trials, according to a company statement. It... |
| - | 6 Precision Medicine partnerships reflective of the new Intel Collaborative Cancer Cloud | Intel just announced it has created a “Collaborative Cancer Cloud,” a precision medicine analytics platform built in partnership with several academic centers. It’s meant to allow researchers from various institutions share the deidentified... |
| - | Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy | Three years after buying a majority stake in Foundation Medicine for more than $1 billion as part of a research and development collaboration, Roche Pharmaceuticals has acquired the rest of the company in a $2.4 billion follow-on deal for t... |
| - | Shining a light on gaps in breast cancer care: A call for increased equity | When we look back on the advent of precision medicine, the health care community will reflect on a boom of high science, groundbreaking research, and a collective advancement of an industry for the benefit of each individual patient. In rec... |
| - | Юрий Мильнер и Билл Гейтс вложились в Foundation Medicine | Пул инвесторов, в числе который совладелец Mail.ru Group Юрий Мильнер и основатель Microsoft Билл Гейтс, вложили $13.5 млн в компанию Foundation Medicine, которая занимается диагностикой раковых заболеваний. Также среди инвесторов раунда ос... |
| - | Pop-up trial sites and the future of personalized oncology care | Gaurav Singal was a successful computer scientist. The language of programming just clicked, he said. But there was a sense of purpose and meaning missing, so he headed off to medical school.
He is now vice president of data strategy and pr... |
| - | Software fast enough for custom-made cancer treatments? | A new approach to review the genetic makeup of cancer patients and their tumors could enable customized cancer treatments.
It’s been too hard for scientists to analyze peoples’ genetic data. Figuring out the details behind a genome can take... |
| - | What’s key to the next cancer breakthrough? The answer may lie in pan-tumor biomarkers | By Brian Alexander, MD, MPH, Chief Medical Officer, Foundation Medicine, Inc.
Targeted cancer treatments, especially immunotherapies, are complex. Understanding in which patients they will work, and just as importantly in which they won’t, ... |
